Oppenheimer Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.57M | Sell |
21,488
-206
| -0.9% | -$91.7K | 0.11% | 210 |
|
|
2025
Q1 | $10.5M | Buy |
21,694
+1,166
| +6% | +$565K | 0.13% | 184 |
|
|
2024
Q4 | $8.27M | Sell |
20,528
-2,862
| -12% | -$1.15M | 0.1% | 222 |
|
|
2024
Q3 | $10.9M | Sell |
23,390
-978
| -4% | -$455K | 0.13% | 180 |
|
|
2024
Q2 | $11.4M | Buy |
24,368
+9,957
| +69% | +$4.67M | 0.15% | 170 |
|
|
2024
Q1 | $6.02M | Sell |
14,411
-2,061
| -13% | -$862K | 0.09% | 251 |
|
|
2023
Q4 | $6.7M | Buy |
16,472
+2,442
| +17% | +$994K | 0.09% | 248 |
|
|
2023
Q3 | $4.88M | Sell |
14,030
-78
| -0.6% | -$27.1K | 0.07% | 286 |
|
|
2023
Q2 | $4.96M | Sell |
14,108
-200
| -1% | -$70.4K | 0.07% | 286 |
|
|
2023
Q1 | $4.51M | Sell |
14,308
-918
| -6% | -$289K | 0.07% | 296 |
|
|
2022
Q4 | $4.4M | Buy |
15,226
+116
| +0.8% | +$33.5K | 0.07% | 291 |
|
|
2022
Q3 | $4.37M | Buy |
15,110
+1,656
| +12% | +$479K | 0.08% | 275 |
|
|
2022
Q2 | $3.79M | Sell |
13,454
-796
| -6% | -$224K | 0.06% | 313 |
|
|
2022
Q1 | $3.72M | Sell |
14,250
-461
| -3% | -$120K | 0.05% | 366 |
|
|
2021
Q4 | $3.23M | Buy |
14,711
+3,268
| +29% | +$718K | 0.04% | 406 |
|
|
2021
Q3 | $2.08M | Sell |
11,443
-17,121
| -60% | -$3.11M | 0.03% | 522 |
|
|
2021
Q2 | $5.76M | Buy |
28,564
+270
| +1% | +$54.4K | 0.08% | 282 |
|
|
2021
Q1 | $6.08M | Buy |
28,294
+394
| +1% | +$84.7K | 0.09% | 249 |
|
|
2020
Q4 | $6.59M | Buy |
27,900
+1,413
| +5% | +$334K | 0.11% | 218 |
|
|
2020
Q3 | $7.21M | Buy |
26,487
+322
| +1% | +$87.6K | 0.14% | 176 |
|
|
2020
Q2 | $7.6M | Sell |
26,165
-5,165
| -16% | -$1.5M | 0.16% | 158 |
|
|
2020
Q1 | $7.45M | Sell |
31,330
-2,558
| -8% | -$609K | 0.18% | 137 |
|
|
2019
Q4 | $7.42M | Sell |
33,888
-3,185
| -9% | -$697K | 0.16% | 164 |
|
|
2019
Q3 | $6.28M | Sell |
37,073
-11,432
| -24% | -$1.94M | 0.14% | 181 |
|
|
2019
Q2 | $8.9M | Sell |
48,505
-302
| -0.6% | -$55.4K | 0.2% | 125 |
|
|
2019
Q1 | $8.98M | Sell |
48,807
-3,805
| -7% | -$700K | 0.2% | 127 |
|
|
2018
Q4 | $8.72M | Sell |
52,612
-1,581
| -3% | -$262K | 0.22% | 107 |
|
|
2018
Q3 | $10.4M | Buy |
54,193
+2,244
| +4% | +$433K | 0.23% | 106 |
|
|
2018
Q2 | $8.83M | Buy |
51,949
+15,114
| +41% | +$2.57M | 0.22% | 113 |
|
|
2018
Q1 | $6M | Buy |
36,835
+11,090
| +43% | +$1.81M | 0.15% | 168 |
|
|
2017
Q4 | $3.91M | Hold |
25,745
| – | – | 0.1% | 235 |
|
|
2017
Q3 | $3.91M | Buy |
25,745
+11,282
| +78% | +$1.71M | 0.1% | 237 |
|
|
2017
Q2 | $1.86M | Buy |
14,463
+6,836
| +90% | +$881K | 0.05% | 376 |
|
|
2017
Q1 | $834K | Buy |
+7,627
| New | +$834K | 0.02% | 632 |
|